Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 01167 JACOBIO-B > Detailed Quotes

01167 JACOBIO-B

4.200
+0.110+2.69%
Trading Session 09/27 15:40 CCT
High
4.210
Open
4.010
Turnover
2.04M
Low
3.990
Pre Close
4.090
Volume
502.20K
Market Cap
3.24B
P/E(TTM)
Loss
52wk High
20.200
Shares
771.46M
P/E(Static)
Loss
52wk Low
3.920
Float Cap
3.24B
Bid/Ask %
-3.97%
Historical High
25.350
Shs Float
771.46M
Volume Ratio
0.70
Historical Low
3.920
Dividend TTM
--
Div Yield TTM
--
P/B
1.83
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.07%
Amplitude
5.38%
Avg Price
4.071
Lot Size
300
Float Cap
3.24B
Bid/Ask %
-3.97%
Historical High
25.350
Shs Float
771.46M
Volume Ratio
0.70
Historical Low
3.920
Dividend TTM
--
P/B
1.83
Dividend LFY
--
Turnover Ratio
0.07%
Amplitude
5.38%
Avg Price
4.071
Lot Size
300
Price Forecast

No Data

News

Comment

Company Overview More
Jiakos Pharmaceutical Group Co., Ltd. is a Chinese investment holding company mainly engaged in clinical drug research and development. The company is mainly responsible for the independent discovery and development of innovative tumor therapy. The company's main drug development projects include JAB-3068 and allosteric SHP2 inhibitors in the clinical phase of JAB-3312. The company mainly does business in the domestic market.
CEO: Yinxiang Wang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...